KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 112 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q4 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,017,317 | -34.5% | 116,138 | -46.9% | 0.00% | -100.0% |
| Q2 2023 | $3,081,183 | +4.1% | 218,834 | -20.4% | 0.00% | – |
| Q1 2023 | $2,959,129 | -48.0% | 275,012 | -27.7% | 0.00% | -100.0% |
| Q4 2022 | $5,695,396 | +48.8% | 380,200 | +27.6% | 0.00% | +100.0% |
| Q3 2022 | $3,827,000 | -8.7% | 298,028 | -31.1% | 0.00% | 0.0% |
| Q2 2022 | $4,193,000 | +49.9% | 432,709 | +53.7% | 0.00% | – |
| Q1 2022 | $2,798,000 | +161.7% | 281,450 | +210.0% | 0.00% | – |
| Q4 2021 | $1,069,000 | -11.7% | 90,785 | -14.5% | 0.00% | – |
| Q3 2021 | $1,210,000 | -58.7% | 106,235 | -49.5% | 0.00% | – |
| Q2 2021 | $2,931,000 | -85.8% | 210,384 | -81.1% | 0.00% | -100.0% |
| Q1 2021 | $20,639,000 | +5.1% | 1,115,023 | +0.3% | 0.01% | 0.0% |
| Q4 2020 | $19,643,000 | +14.2% | 1,111,634 | -1.0% | 0.01% | 0.0% |
| Q3 2020 | $17,202,000 | -6.0% | 1,122,844 | +56.3% | 0.01% | -16.7% |
| Q2 2020 | $18,304,000 | +126.5% | 718,407 | +37.6% | 0.01% | +50.0% |
| Q1 2020 | $8,083,000 | +99.6% | 522,192 | +42.6% | 0.00% | +100.0% |
| Q4 2019 | $4,050,000 | +29.1% | 366,257 | -0.6% | 0.00% | +100.0% |
| Q3 2019 | $3,137,000 | -37.8% | 368,590 | -1.0% | 0.00% | -50.0% |
| Q2 2019 | $5,041,000 | +121.8% | 372,287 | +195.8% | 0.00% | +100.0% |
| Q1 2019 | $2,273,000 | +123.5% | 125,845 | +247.5% | 0.00% | 0.0% |
| Q4 2018 | $1,017,000 | -25.6% | 36,217 | -32.4% | 0.00% | 0.0% |
| Q3 2018 | $1,367,000 | -12.1% | 53,593 | -40.2% | 0.00% | 0.0% |
| Q2 2018 | $1,555,000 | – | 89,616 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,374,392 | $36,376,000 | 4.43% |
| Opaleye Management Inc. | 338,000 | $8,778,000 | 1.72% |
| Lion Point Capital, LP | 495,748 | $7,594,000 | 1.67% |
| Fairmount Funds Management LLC | 212,746 | $3,259,000 | 1.38% |
| Vivo Capital, LLC | 1,151,622 | $17,643,000 | 1.02% |
| Spearhead Capital Advisors, LLC | 270,117 | $4,138,000 | 0.79% |
| Integral Health Asset Management, LLC | 120,000 | $1,838,000 | 0.56% |
| Endurant Capital Management LP | 117,480 | $1,800,000 | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,990 | $3,983,000 | 0.39% |
| Ikarian Capital, LLC | 342,998 | $5,254,000 | 0.38% |